2035
1 clinical trials · Start year
| Record | Firm | Date |
|---|---|---|
| Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease. (NCT07268612) | Emergent BioSolutions | 2035-11-01 |
Track 2035 automatically
Every clearance here is in the API, with alerts when new ones post.